PL2268287T3 - Schemat dawkowania środka przeciwnowotworowego zawierającego pochodną deoksycytydyny - Google Patents
Schemat dawkowania środka przeciwnowotworowego zawierającego pochodną deoksycytydynyInfo
- Publication number
- PL2268287T3 PL2268287T3 PL09738900T PL09738900T PL2268287T3 PL 2268287 T3 PL2268287 T3 PL 2268287T3 PL 09738900 T PL09738900 T PL 09738900T PL 09738900 T PL09738900 T PL 09738900T PL 2268287 T3 PL2268287 T3 PL 2268287T3
- Authority
- PL
- Poland
- Prior art keywords
- antitumor agent
- dosage regimens
- deoxycytidine derivative
- deoxycytidine
- derivative
- Prior art date
Links
- CKTSBUTUHBMZGZ-SHYZEUOFSA-N 2'‐deoxycytidine Chemical class O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 CKTSBUTUHBMZGZ-SHYZEUOFSA-N 0.000 title 1
- 239000002246 antineoplastic agent Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/111,369 US7863255B2 (en) | 2008-04-29 | 2008-04-29 | Methods of administering antitumor agent comprising deoxycytidine derivative |
| PCT/JP2009/058725 WO2009133963A1 (en) | 2008-04-29 | 2009-04-28 | Methods of administering antitumor agent comprising deoxycytidine derivative |
| EP09738900.1A EP2268287B1 (en) | 2008-04-29 | 2009-04-28 | Dosage regimens of an antitumor agent comprising deoxycytidine derivative |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2268287T3 true PL2268287T3 (pl) | 2014-10-31 |
Family
ID=41050984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09738900T PL2268287T3 (pl) | 2008-04-29 | 2009-04-28 | Schemat dawkowania środka przeciwnowotworowego zawierającego pochodną deoksycytydyny |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US7863255B2 (enExample) |
| EP (1) | EP2268287B1 (enExample) |
| JP (1) | JP5570429B2 (enExample) |
| AU (1) | AU2009240908B2 (enExample) |
| DK (1) | DK2268287T3 (enExample) |
| ES (1) | ES2467968T3 (enExample) |
| PL (1) | PL2268287T3 (enExample) |
| WO (1) | WO2009133963A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0625283D0 (en) | 2006-12-19 | 2007-01-24 | Cyclacel Ltd | Combination |
| JP2014001204A (ja) * | 2012-05-23 | 2014-01-09 | Kumamoto Univ | 腫瘍細胞選択的抗がん剤 |
| US11957701B2 (en) | 2020-07-17 | 2024-04-16 | Delta-Fly Pharma, Inc. | Therapy and new therapeutic agent for blood cancer |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2559917B2 (ja) | 1990-06-15 | 1996-12-04 | 三共株式会社 | ピリミジンヌクレオシド誘導体 |
| GB0328180D0 (en) * | 2003-12-04 | 2004-01-07 | Cyclacel Ltd | Combination |
| GB0609530D0 (en) * | 2006-05-12 | 2006-06-21 | Cyclacel Ltd | Combination |
-
2008
- 2008-04-29 US US12/111,369 patent/US7863255B2/en active Active
-
2009
- 2009-04-28 PL PL09738900T patent/PL2268287T3/pl unknown
- 2009-04-28 AU AU2009240908A patent/AU2009240908B2/en active Active
- 2009-04-28 DK DK09738900.1T patent/DK2268287T3/da active
- 2009-04-28 ES ES09738900.1T patent/ES2467968T3/es active Active
- 2009-04-28 JP JP2010535152A patent/JP5570429B2/ja active Active
- 2009-04-28 EP EP09738900.1A patent/EP2268287B1/en active Active
- 2009-04-28 WO PCT/JP2009/058725 patent/WO2009133963A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009240908A1 (en) | 2009-11-05 |
| JP5570429B2 (ja) | 2014-08-13 |
| DK2268287T3 (da) | 2014-06-02 |
| US20090270340A1 (en) | 2009-10-29 |
| US7863255B2 (en) | 2011-01-04 |
| AU2009240908B2 (en) | 2013-10-03 |
| JP2011518761A (ja) | 2011-06-30 |
| ES2467968T3 (es) | 2014-06-13 |
| EP2268287B1 (en) | 2014-05-21 |
| WO2009133963A1 (en) | 2009-11-05 |
| EP2268287A1 (en) | 2011-01-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20181774T1 (hr) | Novi citostatski 7-deazapurinski nukleosidi | |
| ZA201008425B (en) | Suppression of cancers | |
| EP2343066A4 (en) | THERAPEUTIC AGENT FOR HEPATITIS C | |
| GB201019703D0 (en) | Parental formulation of gemcitabine derivatives | |
| IL210855A (en) | Annals of Adenine | |
| PL2421879T3 (pl) | Nowe nukleozydy 7-deazapurynowe do zastosowań terapeutycznych | |
| GB0820970D0 (en) | Suppression of cancer | |
| IL211241A0 (en) | 7-azaindole derivatives | |
| IL196228A0 (en) | 4-hydroxythiobenzamide derivatives of drugs | |
| EP2231687A4 (en) | NEW DERIVATIVES OF ACYL-CYANPYRROLIDINES | |
| IL216417A0 (en) | Compositions and methods to prevent cancer by stabilizing p53 through non mdm2-mediated pathways | |
| EP2370414A4 (en) | PREPARATION OF CAPECITABINE | |
| ZA201108109B (en) | Antitumor combination including cabazitaxel capecitabine | |
| ZA201103627B (en) | Prophylactic/therapeutic agent for cancer | |
| GB0900484D0 (en) | Therapeutic agent | |
| GB0803707D0 (en) | Antiviral agent | |
| ZA200900230B (en) | 4-hydroxythiobenzamide derivatives of drugs | |
| ZA201105310B (en) | High dosage doramectin formulation | |
| PL2268287T3 (pl) | Schemat dawkowania środka przeciwnowotworowego zawierającego pochodną deoksycytydyny | |
| EP2486929A4 (en) | THERAPEUTICS FOR TUMOR | |
| PL387217A1 (pl) | Boranowe pochodne adenozyny | |
| ZA201100163B (en) | Unit dosage of apadenoson | |
| IL197072A0 (en) | Aqueous formulation comprising an antitumor agent | |
| EP2426130A4 (en) | PURINE DERIVATIVE AND ANTITUMOR AGENT USING THE SAME | |
| GB0821710D0 (en) | Derivatives of dihydroindolone |